Among 173 RA patients with overweight or obesity who were prescribed GLP-1 agonists and actually took them, 32% showed improvement in RA disease activity after 1 year, compared with 17% of 42 patients who were also prescribed the drugs but never started them, according to Veena Ranganath, MD, MS, of the University of California Los Angeles (UCLA), and colleagues
Obesity Burden and GLP-1 Treatment Debate Obesity is widely considered one of the most detrimental chronic metabolic conditions afflicting todays human society
Handling is prohibited unless performed by licensed researchers and qualified professionals in controlled laboratory environments.
All records were from a primary prevention registry within the University of Pittsburgh Medical Center multihospital system, which includes over 35 hospitals and 400 outpatient clinics in Pennsylvania, Maryland and West Virginia
Room temperature exposure should not exceed 86F (30C), and storage outside the refrigerator should not exceed 30 days total
Rhodiola Rosea: Reduces stress and fatigue, enhancing mental and physical performance
